The validated 6-variable IsCHEMiA score accurately identifies patients at high risk for developing epilepsy following an acute ischemic stroke.

Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...

Late-onset epilepsy (LOE) may represent a distinctive neurodegenerative-linked epilepsy subtype, with new data showing that individuals who develop epilepsy after midlife have substantially greater ...

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures The CORE-VNS 36-month data analysis reaffirms the effectiveness of VNS Therapy ...

If you have a first seizure as an adult, it could be an indication of epilepsy, or it may be an isolated episode. Causes in adults include a stroke, head trauma, alcohol withdrawal, brain tumor, or ...

Surviving a stroke is a monumental achievement, but for many, the journey to recovery involves navigating new and unexpected ...

LOS ANGELES — Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) cutting the risk by 33%, according to ...

Xenon Pharmaceuticals Inc.'s lead asset, azetukalner (XEN1101), shows promising phase 2b results for focal onset seizures (FOS) and is in phase 3 trials for FOS and PGTCS. Despite failing to meet the ...

When older adults living in nursing homes are prescribed the pain medicine tramadol alongside certain antidepressants, their risk of seizures may go up, according to a study published in Neurology.

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures “It is critically important to conduct long-term, real-world studies like CORE ...